Cynthia J Ladd - Net Worth and Insider Trading

Cynthia J Ladd Net Worth

The estimated net worth of Cynthia J Ladd is at least $645,988 dollars as of 2024-04-27. Cynthia J Ladd is the General Counsel of MyoKardia Inc and owns about 2,851 shares of MyoKardia Inc (MYOK) stock worth over $641,218. Cynthia J Ladd is also the Senior VP and General Counsel of CytomX Therapeutics Inc and owns about 3,000 shares of CytomX Therapeutics Inc (CTMX) stock worth over $4,770. Details can be seen in Cynthia J Ladd's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Cynthia J Ladd has not made any transactions after 2020-01-06 and currently still holds the listed stock(s).

Transaction Summary of Cynthia J Ladd

To

Cynthia J Ladd Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Cynthia J Ladd owns 2 companies in total, including MyoKardia Inc (MYOK) , and CytomX Therapeutics Inc (CTMX) .

Click here to see the complete history of Cynthia J Ladd’s form 4 insider trades.

Insider Ownership Summary of Cynthia J Ladd

Ticker Comapny Transaction Date Type of Owner
MYOK MyoKardia Inc 2020-02-14 General Counsel
CTMX CytomX Therapeutics Inc 2015-10-14 Senior VP and General Counsel

Cynthia J Ladd Latest Holdings Summary

Cynthia J Ladd currently owns a total of 2 stocks. Among these stocks, Cynthia J Ladd owns 2,851 shares of MyoKardia Inc (MYOK) as of January 6, 2020, with a value of $641,218 and a weighting of 99.26%. Cynthia J Ladd also owns 3,000 shares of CytomX Therapeutics Inc (CTMX) as of October 14, 2015, with a value of $4,770 and a weighting of 0.74%.

Latest Holdings of Cynthia J Ladd

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
MYOK MyoKardia Inc 2020-01-06 2,851 224.91 641,218
CTMX CytomX Therapeutics Inc 2015-10-14 3,000 1.59 4,770

Holding Weightings of Cynthia J Ladd


Cynthia J Ladd Form 4 Trading Tracker

According to the SEC Form 4 filings, Cynthia J Ladd has made a total of 1 transactions in MyoKardia Inc (MYOK) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in MyoKardia Inc is the sale of 1,849 shares on January 6, 2020, which brought Cynthia J Ladd around $126,564.

According to the SEC Form 4 filings, Cynthia J Ladd has made a total of 0 transactions in CytomX Therapeutics Inc (CTMX) over the past 5 years. The most-recent trade in CytomX Therapeutics Inc is the acquisition of 3,000 shares on October 14, 2015, which cost Cynthia J Ladd around $36,000.

Insider Trading History of Cynthia J Ladd

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Cynthia J Ladd Trading Performance

GuruFocus tracks the stock performance after each of Cynthia J Ladd's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Cynthia J Ladd is 5.96%. GuruFocus also compares Cynthia J Ladd's trading performance to market benchmark return within the same time period. The performance of stocks bought by Cynthia J Ladd within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Cynthia J Ladd's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Cynthia J Ladd

Average Return

-3.61%

Average return per transaction

Outperforming Transactions

0%

0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -6.11 5.96 2.94 -3.61 26.62 6
Relative Return to S&P 500(%) -7.55 9.59 -1.5 -10.55 13.47 -5.55

Cynthia J Ladd Ownership Network

Ownership Network List of Cynthia J Ladd

No Data

Ownership Network Relation of Cynthia J Ladd


Cynthia J Ladd Owned Company Details

What does MyoKardia Inc do?

Who are the key executives at MyoKardia Inc?

Cynthia J Ladd is the General Counsel of MyoKardia Inc. Other key executives at MyoKardia Inc include director & President and CEO Anastasios Gianakakos , General Counsel Denelle J Waynick , and Chief Business Officer Jake Bauer .

MyoKardia Inc (MYOK) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of MyoKardia Inc (MYOK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of MyoKardia Inc (MYOK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

MyoKardia Inc (MYOK)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

MyoKardia Inc Insider Transactions

No Available Data

Cynthia J Ladd Mailing Address

Above is the net worth, insider trading, and ownership report for Cynthia J Ladd. You might contact Cynthia J Ladd via mailing address: C/o Agy Therapeutics Inc, 290 Utah Ave, South San Francisco Ca 94080.

Discussions on Cynthia J Ladd

No discussions yet.